DK0789844T3 - Anvendelse af et BMP-proteinreceptor-kompleks til screening for aktive stoffer i knoglemetabolisme og celler, der er cotransficieret med en type II-BMP-receptor og en type I-BMP-receptor - Google Patents

Anvendelse af et BMP-proteinreceptor-kompleks til screening for aktive stoffer i knoglemetabolisme og celler, der er cotransficieret med en type II-BMP-receptor og en type I-BMP-receptor

Info

Publication number
DK0789844T3
DK0789844T3 DK95937676T DK95937676T DK0789844T3 DK 0789844 T3 DK0789844 T3 DK 0789844T3 DK 95937676 T DK95937676 T DK 95937676T DK 95937676 T DK95937676 T DK 95937676T DK 0789844 T3 DK0789844 T3 DK 0789844T3
Authority
DK
Denmark
Prior art keywords
bmp
kinase protein
receptor kinase
type
bmp receptor
Prior art date
Application number
DK95937676T
Other languages
English (en)
Inventor
Jan Susan Rosenbaum
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK0789844T3 publication Critical patent/DK0789844T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95937676T 1994-11-04 1995-10-30 Anvendelse af et BMP-proteinreceptor-kompleks til screening for aktive stoffer i knoglemetabolisme og celler, der er cotransficieret med en type II-BMP-receptor og en type I-BMP-receptor DK0789844T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33417894A 1994-11-04 1994-11-04
US08/462,467 US6210899B1 (en) 1994-11-04 1995-06-05 Use of a BMP protein receptor complex for screening bone metabolism actives and cells co-transfected with a type II BMP receptor and type I BMP receptor
PCT/US1995/014027 WO1996014579A1 (en) 1994-11-04 1995-10-30 The use of a bmp protein receptor complex for screening bone metabolism actives and cells co-transfected with a type ii bmp receptor and a type i bmp receptor

Publications (1)

Publication Number Publication Date
DK0789844T3 true DK0789844T3 (da) 2002-05-27

Family

ID=26989071

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95937676T DK0789844T3 (da) 1994-11-04 1995-10-30 Anvendelse af et BMP-proteinreceptor-kompleks til screening for aktive stoffer i knoglemetabolisme og celler, der er cotransficieret med en type II-BMP-receptor og en type I-BMP-receptor

Country Status (8)

Country Link
US (2) US6210899B1 (da)
EP (1) EP0789844B1 (da)
JP (1) JP3527248B2 (da)
AT (1) ATE213064T1 (da)
AU (1) AU710559B2 (da)
DE (1) DE69525366T2 (da)
DK (1) DK0789844T3 (da)
WO (1) WO1996014579A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306622B1 (en) * 1994-11-04 2001-10-23 The Procter & Gamble Co. cDNA encoding a BMP type II receptor
AU4424996A (en) * 1994-12-14 1996-07-03 Amgen Boulder Inc. A tgf-beta superfamily type ii receptor having binding affinity
EP0845006A2 (en) * 1995-08-14 1998-06-03 Creative Biomolecules, Inc. Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof
EP0981745A1 (en) * 1997-05-16 2000-03-01 The Procter & Gamble Company The use of a bone morphogenetic protein (bmp) receptor complex for screening
AU2003230904A1 (en) * 2002-04-12 2003-10-27 Trustees Of Boston University Methods for lightening skin and hair
JP4971149B2 (ja) 2004-06-17 2012-07-11 スラソス セラピューティックス インコーポレーテッド Ｔｄｆ関連化合物およびその類似体
SI2497780T1 (sl) 2005-09-20 2015-08-31 Thrasos Innovation, Inc. Spojine, povezane s TDF, in njihovi analogi
US20070293587A1 (en) * 2006-05-23 2007-12-20 Haley Jeffrey T Combating sinus, throat, and blood infections with xylitol delivered in the mouth
WO2010051032A1 (en) 2008-10-31 2010-05-06 Synthes Usa, Llc Method and device for activating stem cells
KR101451340B1 (ko) 2012-08-02 2014-10-15 (주)애드바이오텍 모발 생장 촉진용 조성물
WO2022232255A2 (en) * 2021-04-28 2022-11-03 The Trustees Of Columbia University In The City Of New York Antibodies for the treatment and prevention of covid-19 and emerging variants

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
ZA874681B (en) 1986-07-01 1988-04-27 Genetics Inst Novel osteoinductive factors
CA2002011A1 (en) 1988-11-14 1990-05-14 Anthony F. Purchio Normal human growth regulatory receptor for tgf-beta
US5168050A (en) 1990-05-24 1992-12-01 Genentech, Inc. Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion
EP0542971A1 (en) 1991-05-10 1993-05-26 The Salk Institute For Biological Studies CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY
US5216126A (en) 1991-06-19 1993-06-01 Genentech, Inc. Receptor polypeptides and their production and uses
DE69232986T2 (de) 1991-10-31 2003-12-11 Whitehead Biomedical Inst TGF-BETA TYP III REZEPTOR, DAFüR KODIERENDE CDNS UND DEREN VERWENDUNG
AU3920693A (en) 1992-03-18 1993-10-21 General Hospital Corporation, The Four novel receptors of the TGF-beta receptor family
AU683431B2 (en) 1992-11-17 1997-11-13 Ludwig Institute For Cancer Research Activin receptor-like kinases, proteins having serine/ threonine kinase domains and their use
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
US6248554B1 (en) 1993-11-24 2001-06-19 The Procter & Gamble Company DNA sequence coding for a BMP receptor

Also Published As

Publication number Publication date
US20030096296A1 (en) 2003-05-22
US7105290B2 (en) 2006-09-12
WO1996014579A1 (en) 1996-05-17
US6210899B1 (en) 2001-04-03
AU710559B2 (en) 1999-09-23
ATE213064T1 (de) 2002-02-15
DE69525366D1 (de) 2002-03-21
DE69525366T2 (de) 2002-11-07
AU3971395A (en) 1996-05-31
JP3527248B2 (ja) 2004-05-17
EP0789844A1 (en) 1997-08-20
JPH10510047A (ja) 1998-09-29
EP0789844B1 (en) 2002-02-06

Similar Documents

Publication Publication Date Title
WO1998035232A3 (en) Electrochemical detection of specific binding
ES8405157A1 (es) Procedimiento de analisis inmunologico.
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
ATE461450T1 (de) Verwendung von kontrollflächen zur detektion von störproben in einem nachweisverfahren
DK0789844T3 (da) Anvendelse af et BMP-proteinreceptor-kompleks til screening for aktive stoffer i knoglemetabolisme og celler, der er cotransficieret med en type II-BMP-receptor og en type I-BMP-receptor
ATE40217T1 (de) Bestimmungsmethode und testsatz fuer proben von vollblut.
AU3395084A (en) Polypeptide-induced monoclonal receptors to protein ligands
ES8703022A1 (es) Procedimiento para detectar al menos un analite en una muestra unica sospechosa de contener mas de un analito.
DE69817794D1 (de) Verfahren zur bestimmung des prozentualen anteils von glykosiliertem hämoglobin
ATE239274T1 (de) Proteom-analyse zum charakterisieren von auf- und abgeregelten proteinen in biologischen proben
DE69928507D1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
WO1995014778A3 (en) Dna sequence coding for a bmp receptor
DE69716305T2 (de) Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)
ATE226727T1 (de) Leistungssteigerung von bindungsassays mit verwendung mehr als einer markierungsmittel
SE9502024D0 (sv) Pathogen assay method
ATE197507T1 (de) Verfahren und verbindungen zur detektion von analyten mittels remanenzmessung und deren verwendung
EP0125893A3 (en) The quantitative analysis of antigen by the enzyme-antibody bridge method
DE69840268D1 (de) Biologisches testverfahren für thyroid stimulierende antikörper
ATA193888A (de) Verfahren zur quantitativen bestimmung des zustandes oder von zustandsaenderungen von inhomogenen proben
EP0392691A3 (en) Assays of coup-transcription factor interactions
GB9114525D0 (en) Homogeneous nucleic acids probe based tests and substances
DE59914992D1 (de) Methode zur zellulären high-throughput-detektion von nukleären rezeptor-liganden-interaktionen
DK0445626T3 (da) Funktionel test til bestemmelse af protein S-aktivitet.
DE59914900D1 (de) Methode zur zellulären high-throughput-detektion von rezeptor-liganden-interaktionen
EP0404590A3 (en) Method of and reagent for the prevention of turbidity